ANDRAS HECZEY to Hepatoblastoma
This is a "connection" page, showing publications ANDRAS HECZEY has written about Hepatoblastoma.
Connection Strength
2.293
-
Incidence and 5-year survival of children and adolescents with hepatoblastoma in the United States. Pediatr Blood Cancer. 2022 10; 69(10):e29763.
Score: 0.597
-
Asynchronous transitions from high-risk hepatoblastoma to carcinoma. J Hepatol. 2026 Jul; 85(1):106-116.
Score: 0.194
-
The impact of congenital heart disease on treatment and survival of patients with hepatoblastoma: A single-center experience. Pediatr Blood Cancer. 2024 11; 71(11):e31214.
Score: 0.174
-
A novel treatment strategy utilizing panobinostat for high-risk and treatment-refractory hepatoblastoma. J Hepatol. 2024 04; 80(4):610-621.
Score: 0.167
-
Navigating relapsed hepatoblastoma: Predictive factors and surgical treatment strategy. Cancer Med. 2023 12; 12(23):21270-21278.
Score: 0.165
-
Hepatoblastomas with carcinoma features represent a biological spectrum of aggressive neoplasms in children and young adults. J Hepatol. 2022 10; 77(4):1026-1037.
Score: 0.149
-
Integration of a dedicated management protocol in the care of pediatric liver cancer: From specialized providers to complication reduction. J Pediatr Surg. 2022 Aug; 57(8):1544-1553.
Score: 0.141
-
Liver transplant in a recently COVID-19 positive child with hepatoblastoma. Pediatr Transplant. 2021 08; 25(5):e13880.
Score: 0.134
-
Pediatric Oncology Patients With Vincristine-Induced Recurrent Laryngeal Nerve Palsy: Two Case Reports and a Brief Review of Literature. Ear Nose Throat J. 2021 Dec; 100(10):NP459-NP463.
Score: 0.130
-
Agenesis of the corpus callosum and hepatoblastoma. Am J Med Genet A. 2020 01; 182(1):224-228.
Score: 0.125
-
Fatal Central Nervous System Post-Transplant Lymphoproliferative Disease in a Patient Who Underwent Liver Transplantation for Hepatoblastoma. J Pediatr Gastroenterol Nutr. 2018 01; 66(1):e21-e23.
Score: 0.110
-
Vascular invasion is a prognostic indicator in hepatoblastoma. J Pediatr Surg. 2017 Jun; 52(6):956-961.
Score: 0.104
-
Genomic analysis of hepatoblastoma identifies distinct molecular and prognostic subgroups. Hepatology. 2017 01; 65(1):104-121.
Score: 0.102